Cosentyx (secukinumab) is an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation. Cosentyx is used to treat moderate to severe plaque psoriasis (raised, silvery flaking of the skin), ankylosing spondylitis, and psoriatic arthritis in adults. This human IgG1 monoclonal antibody that selectively binds to the interleukin-17A (IL-17A) cytokine and inhibits its interaction with the IL-17 receptor. IL-17A is a naturally occurring cytokine that is involved in normal inflammatory and immune responses.
The cosentyx drug market is segmented based on type, application, and geography. On the basis of type, cosentyx drug market divided into sensoready pen and prefilled syringe. Further, the cosentyx drug market is segmented by application into hospital and drugs store. Geographically, the cosentyx drug market is sub-divided into North America, Europe, Asia-Pacific, and Rest of the world.
The key market players operating in the cosentyx drug market include Novartis.
COSENTYX DRUG MARKET SEGMENTS
Market By Type
• Sensoready Pen
• Prefilled Syringe
Market By Application
• Hospital
• Drugs Store
Market By Geography
• North America
• Europe
• Asia-Pacific
• Rest of the world
Key Players
• Novartis
Global Cosentyx Drug Market Forecast - Global Cosentyx Drug Market Growth, Market Trends and Forecast
© 2019 Data N Analysis. All Rights Reserved | Design by Data N Analysis